Spastic paresis after perinatal brain damage in rats is reduced by human cord blood mononuclear cells. - Wikidata - awgldk - TriplyDB

Spastic paresis after perinatal brain damage in rats is reduced by human cord blood mononuclear cells.

Spastic paresis after perinatal brain damage in rats is reduced by human cord blood mononuclear cells.

http://www.wikidata.org/entity/Q48671598

about

Neuroprotective Strategies after Neonatal Hypoxic Ischemic Encephalopathy What are the Best Animal Models for Testing Early Intervention in Cerebral Palsy?The potential for stem cell therapies to have an impact on cerebral palsy: opportunities and limitations Human Umbilical Cord Blood Cells Ameliorate Motor Deficits in Rabbits in a Cerebral Palsy Model Stem Cells: Potential Therapy for Neonatal Injury?Cerebral Palsy-Trends in Epidemiology and Recent Development in Prenatal Mechanisms of Disease, Treatment, and Prevention First autologous cell therapy of cerebral palsy caused by hypoxic-ischemic brain damage in a child after cardiac arrest-individual treatment with cord blood Autologous cord blood therapy for infantile cerebral palsy: from bench to bedside.Outcomes of autologous bone marrow mononuclear cells for cerebral palsy: an open label uncontrolled clinical trial.Human umbilical cord blood cells restore brain damage induced changes in rat somatosensory cortex.Internal ribosomal entry site (IRES) activity generates endogenous carboxyl-terminal domains of Cx43 and is responsive to hypoxic conditions.Hypothermia for hypoxic-ischemic encephalopathy.Umbilical cord blood mononuclear cell transplantation for neonatal hypoxic-ischemic encephalopathy.Cell therapy for neonatal hypoxia-ischemia and cerebral palsy.Could cord blood cell therapy reduce preterm brain injury?The potential of cord blood stem cells for use in regenerative medicine.Cell Therapy From Bench to Bedside Translation in CNS Neurorestoratology Era.Systemic injection of CD34(+)-enriched human cord blood cells modulates poststroke neural and glial response in a sex-dependent manner in CD1 mice.Application of Umbilical Cord Blood Derived Stem Cells in Diseases of the Nervous System The olfactory bulb in newborn piglet is a reservoir of neural stem and progenitor cells.Neuronal cell reconstruction with umbilical cord blood cells in the brain hypoxia-ischemia.The enhanced ability of peripheral mononuclear cells differentiating into neural cells in term infants with good improvement suffering from severe hypoxic ischemic encephalopathy.A possible new focus for stroke treatment - migrating stem cells Is it time to rethink cord management when resuscitation is needed?Effects of Placental Transfusion on Neonatal and 18 Month Outcomes in Preterm Infants: A Randomized Controlled Trial.Human umbilical cord blood mononuclear cells and chorionic plate-derived mesenchymal stem cells promote axon survival in a rat model of optic nerve crush injury.First Autologous Cord Blood Therapy for Pediatric Ischemic Stroke and Cerebral Palsy Caused by Cephalic Molding during Birth: Individual Treatment with Mononuclear Cells.The potential for cell-based therapy in perinatal brain injuries.Umbilical cord blood therapy potentiated with erythropoietin for children with cerebral palsy: a double-blind, randomized, placebo-controlled trial Treatment of Cerebral Palsy with Stem Cells: A Report of 17 Cases.Differences in quality between privately and publicly banked umbilical cord blood units: a pilot study of autologous cord blood infusion in children with acquired neurologic disorders.Mankind's first natural stem cell transplant.Perinatal neuroprotection.Hindlimb spasticity after unilateral motor cortex lesion in rats is reduced by contralateral nerve root transfer.Future of cord blood for non-oncology uses.Placental transfusion: a review.Feasibility of autologous cord blood cells for infants with hypoxic-ischemic encephalopathy.The treatment of neurodegenerative disorders using umbilical cord blood and menstrual blood-derived stem cells.Human umbilical cord blood stem cells: rational for use as a neuroprotectant in ischemic brain disease.Stem cell therapy for neonatal brain injury: perspectives and challenges.

P2860

Q26782756-17927AD9-5E4C-458B-B5FD-F81D6ED98BB6 Q26829589-88C88393-C237-481F-B10C-EFC8CE28763C Q26860841-9BD218F7-602A-408D-97E5-E630917EA470 Q27345014-594862E3-6B8A-4DBA-A7FB-7851009381D0 Q28082268-9162CD68-ADCD-413A-9760-114E2344DC3D Q30235534-F109F0C9-399B-4876-8214-F227562CC66F Q30453572-37CB945A-C92B-4A2B-A2F4-09E799248FD7 Q30574180-ABF239DC-1BC8-4E87-A3D9-7D0B179CBDD0 Q33556222-9CFBBC93-EE2E-487C-9A3B-858FDA670F83 Q33932727-37D5F5CA-072A-4051-AC87-9DBD3D2D26D4 Q33947209-3762D98B-62BD-4E08-9C58-C3B936DA3649 Q33961885-E67F1C31-64BE-4B16-ABDA-6A37C96FA2A7 Q34202309-9FEFD5AD-D51A-493B-88B3-476D220E112A Q34269972-9EFC26B2-908E-4CD4-B7DF-29132B4B4E18 Q34312137-E640B35E-742C-40F5-9AED-DAC6CA5B18E5 Q34582143-4E269E4C-A2F6-4646-8724-5E1CD2304B61 Q34595662-315502A5-6A1D-4003-BFB9-2F952D5A1029 Q34751529-DB11FE37-D3F6-404A-A919-B4E22A4A4996 Q34975310-F1047778-A135-476D-A1B2-B39A879648D8 Q35053888-6339ED15-905F-4985-832C-696F41120272 Q35065403-C33621A6-A527-452D-A15B-8E911EF4A3CF Q35118554-7A6C64E6-CF84-414B-B2F2-87C1E7C481EB Q35738018-EA7248F0-858B-48C0-BFD0-6ED7D42B3D87 Q36402412-9D6331A8-E978-4E34-82BA-616B7F48069A Q36421386-0C042831-F5B9-4178-80F8-9E65AED7998F Q36791214-D9739382-647D-470D-952B-FB27C7B45B4A Q36901400-4F6A9B75-AD27-43B9-A7D9-F1B0277A7EEC Q36954954-7952A200-258B-4142-9D7C-B3924990ABAC Q37098276-A83419F8-4591-48BD-878E-22F891120A4E Q37126560-2731FD3C-5F00-4781-82A8-2030AC6A2B79 Q37277064-28B6EEC6-5C10-4576-AB20-C7DBC33DAC11 Q37296284-2D1FD356-8E59-46FA-B584-0DEE715F8127 Q37444015-AF52F5E4-267F-4E0F-A4C6-E59DD8C8E496 Q37529402-D18B6C65-9FB7-4E8B-A3EA-64A64EEE80BA Q37607982-12FF335A-4B78-40A0-9BB0-7276AAE216D7 Q37622567-021AA95A-1039-4E3D-8175-D3007F42E6E3 Q37710965-B703C89F-CF9C-465C-9934-7CBA33A76E70 Q37795969-6A5AC0A6-5DD1-42E5-951C-07095CB373A0 Q37801289-2C278FF8-4084-4236-BDC9-293DFD690C4B Q37967608-82DBDE92-086F-4536-814A-F3791CE3ADAA

P2860

Spastic paresis after perinatal brain damage in rats is reduced by human cord blood mononuclear cells.

http://www.wikidata.org/entity/Q48671598

description

2006 nî lūn-bûn

@nan

2006年の論文

@ja

2006年学术文章

@wuu

2006年学术文章

@zh

2006年学术文章

@zh-cn

2006年学术文章

@zh-hans

2006年学术文章

@zh-my

2006年学术文章

@zh-sg

2006年學術文章

@yue

2006年學術文章

@zh-hant

name

Spastic paresis after perinata ...... cord blood mononuclear cells.

@en

Spastic paresis after perinata ...... cord blood mononuclear cells.

@nl

type

label

Spastic paresis after perinata ...... cord blood mononuclear cells.

@en

Spastic paresis after perinata ...... cord blood mononuclear cells.

@nl

prefLabel

Spastic paresis after perinata ...... cord blood mononuclear cells.

@en

Spastic paresis after perinata ...... cord blood mononuclear cells.

@nl

P1433

Q48671598-AC60209A-8CA5-45B0-B8F7-C462EC687106

P1476

Q48671598-AFC1FB8A-5C1B-47A0-9BCE-2DB1598F67AA

P2093

Q48671598-70F4BF3D-0478-4CD2-8CDB-017AD52771D6

Q48671598-9FA19A27-8B0A-445E-A6C7-D314F1B2A19E

Q48671598-A4D5020C-383F-4BB6-A133-5CF3FC646856

Q48671598-A84E5C10-D408-49ED-8FD9-F10EF4900601

Q48671598-B012DA56-823C-4CBE-8D46-71FAA8792C3D

Q48671598-BA42B535-E215-4334-B9E5-062E142507D2

Q48671598-E0B98D40-3ECE-4CB2-B392-04AC2094890F

P2860

Q48671598-0AB5E4E7-8548-4A0F-90DE-E06CDE4AB09C

Q48671598-116E2906-64EF-498B-9439-3DEA0A12108F

Q48671598-3345DC45-0174-4308-ACD6-4C28A43FE8CF

Q48671598-3A82E877-9661-4BEB-961D-AE579B536B34

Q48671598-4B1E5787-BA6A-4BB4-A9F4-A057798C80D2

Q48671598-5B59F873-36F3-4E33-BB8B-E64172D00A0B

Q48671598-6E4DB24A-6915-4C72-B9C1-613CB4740ED0

Q48671598-9D964BC4-2E86-460A-B0DF-3900CC283E12

Q48671598-A07E8BB5-4743-4117-8946-EF824DB0C005

Q48671598-ADD89CB6-C1E2-4462-88E0-BB9B7ACB6D24

P2888

Q48671598-FD748858-6DD5-47CA-8575-C1E6940E2638

P304

Q48671598-230B84AD-ED99-4CF2-80AC-362387519949

P31

Q48671598-A6595628-E6C0-4E2C-80B0-AD8495290EE6

P356

Q48671598-F8E2E9DA-7068-4BA9-AD43-2DA96F258169

P407

Q48671598-73409104-014B-4F9C-B6C7-AF38BA0F79F0

P433

Q48671598-93D06C0F-A81B-499E-BB46-1CC5EA09D3E3

P478

Q48671598-2E325652-B18D-4EE7-AF19-FB322BDB0CAF

P50

Q48671598-01A1F14C-CB75-4FBF-B57C-548E93212EC5

Q48671598-A08D30C6-D0C7-4C7F-AE05-7976B1800130

P577

Q48671598-51A20357-BDA3-41FB-B350-5EC22EA79502

P5875

Q48671598-94180641-2B7C-4A80-BD73-7B8CA8B2FA61

P6179

Q48671598-C3985881-448F-4ECD-B511-A5977B3643E6

P698

Q48671598-B8C93B6D-B6DD-44A9-98D0-A89FD87146C5

P356

01.PDR.0000197309.08852.F5

P1433

Pediatric Research

P1476

Spastic paresis after perinata ...... n cord blood mononuclear cells

@en

P2093

Astrid Roth-Haerer

http://www.w3.org/2001/XMLSchema#string

Bianca Wasielewski

http://www.w3.org/2001/XMLSchema#string

Carola Meier

http://www.w3.org/2001/XMLSchema#string

Hubert R Dinse

http://www.w3.org/2001/XMLSchema#string

Johannes Middelanis

http://www.w3.org/2001/XMLSchema#string

Markus Gantert

http://www.w3.org/2001/XMLSchema#string

Sandra Neuhoff

http://www.w3.org/2001/XMLSchema#string

P2860

Transplantation of umbilical-cord blood in babies with infantile Krabbe's disease

Transplantation of neural progenitor and stem cells: developmental insights may suggest new therapies for spinal cord and other CNS dysfunction.

Chemokine and inflammatory cell response to hypoxia-ischemia in immature rats.

Neural stem cells display an inherent mechanism for rescuing dysfunctional neurons.

Perinatal brain damage--from pathophysiology to prevention.

The injury response in the term newborn brain: can we neuroprotect?

A new human somatic stem cell from placental cord blood with intrinsic pluripotent differentiation potential.

Neural stem cells constitutively secrete neurotrophic factors and promote extensive host axonal growth after spinal cord injury.

Hypoxia-ischemia in the neonatal rat brain: histopathology after post-treatment with NMDA and non-NMDA receptor antagonists.

Interleukin 10, produced in abundance by human newborn T cells, may be the regulator of increased tolerance associated with cord blood stem cell transplantation.

P2888

01.pdr.0000197309.08852.f5

P304

244-249

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1203/01.PDR.0000197309.08852.F5

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

59

http://www.w3.org/2001/XMLSchema#string

P50

Rolf Dermietzel

P577

2006-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7333251

http://www.w3.org/2001/XMLSchema#string

P6179

1022373812

http://www.w3.org/2001/XMLSchema#string

P698

16439586

http://www.w3.org/2001/XMLSchema#string